Clinical Trials Logo
  1. Home
  2. Oral Contraceptive
  3. NCT02021097

Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception

Oral Contraceptive Clinical Trial

Official title:
A Multicenter, Randomized, Open-labe, Controlled Study to Evaluate the Efficacy and Safety of the Combined Levonorgestrel(LNG) 100mcg and Ethinyl Estradiol(EE) 20mcg for Oral Contraception

Clinical Trial Summary

The purpose of this study is to evaluate the contraceptive efficacy and safety of an oral contraceptive containing a combination of LNG 100mcg/EE 20mcg compared to LNG 150mcg/EE 30 mcg.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02021097
Study type Interventional
Source Regenex Pharmaceutical, China
Contact Chengliang Xiong, Dr
Email clxiong951@sina.cn
Status Recruiting
Phase Phase 3
Start date February 2012
Completion date February 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT01388491 - A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women Phase 2
Completed NCT01252186 - A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women Phase 2
Not yet recruiting NCT06426459 - Social Media Usage in Adolescent Girls
Recruiting NCT02398903 - Evaluation of Hormonal Contraceptive Treatments in Obese Women
Completed NCT00302666 - Bleeding Pattern Study Phase 3
Completed NCT00739622 - TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women. Phase 1
Completed NCT01291004 - A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives Phase 1
Recruiting NCT01318005 - Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation N/A
Completed NCT00778609 - Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache Phase 3
Completed NCT00972439 - Oral Contraceptive (OC) Progestin Dose and Breast Proliferation N/A
Completed NCT01076582 - Comparative Trial in Hormone Withdrawal Associated Symptoms Phase 3
Completed NCT00471991 - Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition Phase 2
Completed NCT00248963 - Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception Phase 3